ReviewCurrent pharmaceutical design2026
Corticosteroids for Nerve Regeneration: A Narrative Review.
Review in Current pharmaceutical design, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A review of new developments in peripheral nerve regeneration.Biochemistry and biophysics reports · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite the use of advanced microsurgical techniques, around one-third of peripheral nerve injuries still show inadequate functional regeneration and incomplete healing. Peri- and intraneural nerve damage leads to pathophysiologic alterations, including morphological and metabolic changes, where the nerve is disrupted. Animal research shows no proven adjustment drugs for peripheral nerve regeneration, but studies suggest medicines can speed up regeneration using functional and histological parameters after nerve injury. Factors affecting nerve regeneration effectiveness include injury type, age, regeneration time, procedures, and materials. Complete regeneration and functional recovery are rarely achieved, regardless of the kind of pharmaceutical therapy used, necessitating further research into nerve regeneration. Future research could enhance corticosteroid doses with additional drugs, increasing clinical use. This review explores the mechanism of action of corticosteroids Dexamethasone, Betamethasone, and Methylprednisolone in peripheral nerve regeneration experiments, highlighting the potential for enhanced nerve injury.
Indexed as
Identifiers
40551692What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.